Statement: 1 patient in the primary trial was diangosed with Influenza.
Primary_evidence: Adverse Events 1:   Total: 29/110 (26.36%)   Atrial fibrillation 1/110 (0.91%)   Nausea 2/110 (1.82%)   Abdominal pain 1/110 (0.91%)   Abdominal pain upper 1/110 (0.91%)   Constipation 1/110 (0.91%)   Pancreatitis 1/110 (0.91%)   Vomiting 1/110 (0.91%)   Pyrexia 3/110 (2.73%)   Axillary pain 2/110 (1.82%)   Chest pain 1/110 (0.91%)   Influenza like illness 1/110 (0.91%) Adverse Events 2: